Senti Bio appoints Kanya Rajangam as President; CEO Lu remains CEO

Senti Biosciences, Inc.

Tim Lu stepped down as President effective May 14, 2024, but continues as CEO.
Kanya Rajangam, M.D., Ph.D., appointed President; she remains Head of R&D and CMO.
Rajangam joined Senti in July 2022; prior CMO at Nkarta (NKTX) and Atara (ATRA).
Her compensation includes $490K base salary, 40% target bonus, option grant, and severance per 2022 offer letter.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kanya Rajangam

President

SNTI · Senti Biosciences, Inc.

Effective: 2024-05-14
Filed: May 17, 2024, 7:59 PM ET

Kanya Rajangam, M.D., Ph.D., the Company's Head of Research and Development, and Chief Medical Officer, was appointed to serve as the President of the Company, effective as of May 14, 2024

Role change

Timothy Lu

President

SNTI · Senti Biosciences, Inc.

Effective: 2024-05-14
Successor: Kanya Rajangam
Filed: May 17, 2024, 7:59 PM ET

Timothy Lu, M.D., Ph.D., Chief Executive Officer and President, stepped down as President

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Kanya Rajangam was appointed as President at Senti Biosciences, Inc..

Action: appointed
Role: President

Exact text from the filing

Kanya Rajangam, M.D., Ph.D., the Company's Head of Research and Development, and Chief Medical Officer, was appointed to serve as the President of the Company, effective as of May 14, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Timothy Lu changed role as President at Senti Biosciences, Inc..

Action: stepped down
Role: President

Exact text from the filing

Timothy Lu, M.D., Ph.D., Chief Executive Officer and President, stepped down as President

View on SEC.gov

Senti Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0001854270-24-000061

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.